AUS
NZ
UK
CA
USA
IND
Summary
- AIM listed stocks not only present ample opportunity to enlarge the wealth with stock market investment but also make investors eligible for various government-sponsored tax reliefs
- There are many AIM listed stocks that have already delivered more than 100 per cent of return in the year so far.
AIM, a sub-market of the London Stock Exchange (LSE) was launched in the year 1995 to replace the Unlisted Securities Market (USM). The FTSE comprises three indices for the stocks listed on AIM - FTSE AIM All-Share, FTSE AIM 100, and FTSE AIM UK 50. This AIM index enables smaller and less developed companies that require a more flexible governance approach to float shares on the market. AIM listed stocks not only present ample opportunity to enlarge the wealth with stock market investment but also make investors eligible for various government-sponsored tax reliefs.
There are many AIM listed stocks that have already delivered more than 100 per cent of return in the year so far. Here we take a look at some of the hidden gems on AIM, selected based on their year-to-date returns and market capitalisation.
Renalytix Plc (LON: RENX)
Renalytix is an artificial intelligence-powered in vitro diagnostics firm engaged in optimising clinical disease management and risk assessment of kidney diseases through the KidneyIntelX platform. The US General Services Administration granted the company a 10-year contract for KidneyIntelX testing services at $950 for each reportable result.
For the quarter ended 31 March 2021, Renalytix recorded $0.6 million of services revenue. While cash, cash equivalents and short-term investments stood at $70.1 million for the period compared to $14.3 million as of 30 June 2020.
Renalytix’s shares have a year-to-date return of 104.77 per cent, and its market capitalisation stood at £743.97 million as of 09 August 2021.
Angle Plc (LON:AGL)
Angle Plc is a company engaged in providing liquid biopsy services across the globe. Angle completed two separate clinical studies on 200 subjects to develop an ovarian cancer pelvic mass triage test, with the results showing 95.1 per cent accuracy (AUC-ROC). Its Parsortix technology has been granted 26 patents in the United States, China, Europe, Australia, India, Canada, Mexico, and Japan.
Angle set up clinical services laboratories in the US and the UK to speed up the commercialisation of the Parsortix system and serve as demonstrators to enable product development. These laboratories also provide services to biotechnology and pharmaceutical companies to use the system in trials of cancer drugs.
Angle’s shares have a year-to-date return of 121.16 per cent, and its market capitalisation stood at £248.26 million as of 09 August 2021.
Copyright © 2021 Kalkine Media
Sanderson Design Group Plc (LON:SDG)
Sanderson Design Group is a provider of premium interior design and furnishing products. The sales of the company in the first 23 weeks of the financial year (ended on 31 July 2021) stood at £50.9 million (it includes manufacturing and brand product sales of £47.9 million), an increase of 39.8 per cent compared to the same period ended on 31 July 2020, and 1.4 per cent increase compared to the same period in 2020. The pent-up demand for home interiors solutions during the pandemic coupled with the high demand for British design and manufacturing post-Brexit helped the company.
Sanderson Design Group’s shares have a year-to-date return of 126.97 per cent, and its market capitalisation stood at £143.39 million as of 09 August 2021.
RBG Holdings Plc (LON:RBGP)
RBG Holdings is a company engaged in offering professional and legal services. For the year ended 31 December 2020, the group revenue and profit from litigation assets increased by 8 per cent to £25.6 million (2019: £23.7 million), and revenue in legal and professional services rose by 12.6 per cent to £22.4 million (2019: £19.9 million). EBITDA increased to £10.2 million (2019: £9.4 million), with EBITDA margins of 40 per cent. Net cash for the period was £3.5 million compared to £1.9 million in 2019.
On 16 July 2021, the board of the company announced plans to pay an interim dividend of 2 pence per share for the six months ended on 30 June 2021, on 27 August 2021 to shareholders.
RBG Holdings’ shares have a year-to-date return of 132.95 per cent, and its market capitalisation stood at £131.08 million as of 09 August 2021.
Warpaint London Plc (LON:W7L)
Warpaint London is a company engaged in the supply of specialist colour cosmetics. The company also owns Technic and W7 brands. For the year ended 31 March 2021, Warpaint London’s revenue stood at £40.3 million, a drop from the previous year’s £49.3 million, due to the impact of the Covid-19 pandemic and temporary closures of retail outlets. It recorded a pre-tax loss tax of £1.1 million in 2020 compared to a pre-tax profit of £1.8 million in 2019. On 11 June 2021, Warpaint recommended a final dividend of 3.0 pence per share.
Warpaint London’s shares have a year-to-date return of 110.83 per cent, and its market capitalisation stood at £124.72 million as of 09 August 2021.
